Novel Use Of Rheum Drugs In Covid-19

Novel Use of Rheum Drugs in COVID-19 (5.1.20)

Rheumatology and Rehabilitation: COVID-19 and the use of rheumatology drugs

Royal Society of Medicine

ACR and COVID-19 Update: Our Response and Resources for You

American College of Rheumatology

COVID-19 and Rheumatology

AlbertaRheumatology

Outcomes of COVID in Rheumatic Disease Patients: Dr. Eric Dein

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

Medicine Matters rheumatology

Repurposing rheumatology drugs for COVID-19: What do we know? (with Jinoos Yazdany)

Medicine Matters rheumatology

Repurposing rheumatology drugs for COVID-19: JAK inhibitors

Medicine Matters rheumatology

Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)

Medicine Matters rheumatology

Study finds link between RA treatment and COVID-19 severity | Jeffrey Sparks and Zachary Wallace

Medicine Matters rheumatology

TNR - COVID-Rheumatology Registry & COVID in OZ

Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19

The Journal of Rheumatology

Covid-19 and the use of antirheumatic drugs

Dr. Diana Girnita - Rheumatologist OnCall

Drug used to treat rheumatoid arthritis & COVID-19 in short supply

COVID-19 Update for Patients with Autoimmune Disease: Rheumatology Perspective

Emory Department of Medicine

Rituximab use in the COVID-19 era: Striking the right balance | Sebastian Sattui and David Jayne

Medicine Matters rheumatology

How has COVID-19 Affected Your Rheumatology Practice? - Virginia Reddy, MD

American College of Rheumatology

TNR Grand Rounds - -What does COVID-19 have to do with lupus?

Rheumatologic patient COVID-19 experience

The Journal of Rheumatology

Brian LaMoreaux, MD: Practicing Rheumatology During and After COVID-19